Breast Cancer and Use of Nonsteroidal Anti-inflammatory Drugs: A Meta-analysis

Background Breast cancer is one of the leading causes of mortality among women. The use of nonsteroidal anti-inflammatory drugs (NSAIDs) may be associated with reduced risk for breast cancer, but results from these studies of the association have been inconsistent. Methods Studies that examined the...

Full description

Saved in:

Bibliographic Details
Published in:	JNCI : Journal of the National Cancer Institute 2008-10, Vol.100 (20), p.1439-1447
Main Authors:	Takkouche, Bahi, Regueira-Méndez, Carlos, Etminan, Mahyar
Format:	Article
Language:	eng
Subjects:	Anti-Inflammatory Agents, Non-Steroidal - administration & dosage Aspirin - administration & dosage Biological and medical sciences Breast cancer Breast Neoplasms - epidemiology Breast Neoplasms - prevention & control Case-Control Studies Cohort Studies Disease prevention Gynecology. Andrology. Obstetrics Humans Ibuprofen - administration & dosage Mammary gland diseases Medical sciences Meta-analysis Nonsteroidal anti-inflammatory drugs Oncology Risk Factors Tumors
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Background Breast cancer is one of the leading causes of mortality among women. The use of nonsteroidal anti-inflammatory drugs (NSAIDs) may be associated with reduced risk for breast cancer, but results from these studies of the association have been inconsistent. Methods Studies that examined the association between risk of breast cancer and use of NSAIDs, including aspirin and ibuprofen, that were published between January 1, 1966, and July 1, 2008, were identified using Medline, EMBASE, and other databases. We performed meta-analysis by pooling studies according to the inverse of their variances and performed separate analyses of studies pooled according to aspirin use and ibuprofen use. We evaluated publication bias and study quality. Results A total of 38 studies (16 case–control studies, 18 cohort studies, 3 case–control studies nested in well-defined cohorts, and 1 clinical trial) that included 2 788 715 subjects were identified. The results of these studies suggest that overall, NSAID use was associated with reduced risk for breast cancer (relative risk [RR] = 0.88, 95% confidence interval [CI] = 0.84 to 0.93). Specific analyses for aspirin (RR = 0.87, 95% CI = 0.82 to 0.92) and ibuprofen (RR = 0.79, 95% CI = 0.64 to 0.97) yielded similar results. Conclusions This meta-analysis provides evidence that NSAID use is associated with reduced risk for breast cancer. Future research should include careful evaluation of the biologic mechanisms involved in the relationship between NSAIDs and breast cancer.
ISSN:	0027-8874 1460-2105